A successful treatment with ustekinumab in a case of relapsing bullous pemphigoid associated with psoriasis.
Fiche publication
Date publication
octobre 2016
Journal
Journal of the European Academy of Dermatology and Venereology : JEADV
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ANTONICELLI Franck
Tous les auteurs :
Loget J, Plee J, Antonicelli F, Bernard P
Lien Pubmed
Résumé
Predisposing factors for bullous pemphigoid (BP), the most common autoimmune blistering disease, include neurological disorders, chronic use of certain drugs (spironolactone, loop diuretics, psycholeptics).(1) The coexistence of psoriasis with classical BP is occasionally observed, whereas half of the patient population with anti-laminin γ1 pemphigoid of Japanese origin have coexisting psoriasis.(2-3) We report for the first time a case of relapsing BP associated with psoriasis, in which both dermatoses completely disappeared after treatment with ustekinumab, a monoclonal antibody that targets the p40 subunit of IL-12/23. This article is protected by copyright. All rights reserved.
Référence
J Eur Acad Dermatol Venereol. 2016 Oct;: